Remove Access Remove Clinical Trials Remove Collective Remove White Paper
article thumbnail

Dalrada Corporation Expands Presence in Top Three Growth Industries: Clean Energy, Healthcare, Technology (IT)

Cannabis Law Report

Tests include on-site rapid antigen (results in under 20 minutes) and on-site RT-PCR sample collection (results in 24 hours). Yet, more than half of the people in the least developed countries lack access to electricity. The second phase of cerVIA™ clinical trials in India is complete, with white paper submissions underway.